{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:29:22Z","timestamp":1790922562730,"version":"4.1.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,1]]},"abstract":"Abstract<\/jats:title>\n \n STUDY QUESTION<\/jats:title>\n Does polycystic ovary syndrome (PCOS) confer an independent risk for adverse delivery and neonatal outcomes, based on analysis of the Healthcare Cost and Utilization Project-Nationwide Inpatient Sample (HCUP-NIS) database?<\/jats:p>\n <\/jats:sec>\n \n SUMMARY ANSWER<\/jats:title>\n After controlling for all potential confounding effects, women with PCOS are at an increased risk of experiencing preterm pre-labour rupture of membranes (PPROM), pre-term delivery (PTD), placental abruption, caesarean section (C\/S) delivery, chorioamnionitis and post-partum maternal infections.<\/jats:p>\n <\/jats:sec>\n \n WHAT IS KNOWN ALREADY<\/jats:title>\n PCOS may be associated with an increased risk of adverse perinatal outcomes. However, there remain significant gaps in understanding the correlation between PCOS and important delivery and neonatal complications.<\/jats:p>\n <\/jats:sec>\n \n STUDY DESIGN, SIZE, DURATION<\/jats:title>\n This is a retrospective population-based cohort study utilising data from the HCUP-NIS over 11 years from 2004 to 2014. A cohort of all deliveries between 2004 and 2014 inclusively was created. Within this group, all deliveries to women with PCOS were identified as part of the study group (n\u2009=\u200914\u00a0882), and the remaining deliveries were categorised as non-PCOS births and comprised the reference group (n\u2009=\u20099\u00a0081\u00a0906).<\/jats:p>\n <\/jats:sec>\n \n PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n The HCUP-NIS is the largest inpatient sample database in the USA and it is comprised of hospital inpatient stays throughout the entire country. It provides information relating to 7 million inpatient stays per year, includes \u223c20% of admissions, and represents over 96% of the American population.<\/jats:p>\n <\/jats:sec>\n \n MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n After adjustment for all potential confounders, women with PCOS were more likely to experience PPROM (aOR 1.48, 95% CI 1.20\u20131.83), PTD (aOR 1.37 95% CI 1.24\u20131.53) and placental abruption (aOR 1.63, 95% CI 1.30\u20132.05) and were more likely to deliver by C\/S (aOR 1.50, 95% CI 1.40\u20131.61 (all P\u2009&lt;\u20090.001). Women with PCOS more often developed chorioamnionitis (aOR 1.58, 95% CI 1.34\u20131.86, P\u2009&lt;\u20090.001) and maternal infections (aOR 1.58, 95% CI 1.36\u20131.84 (both P\u2009&lt;\u20090.001)). With the exception of multiple gestations (aOR 1.27, 95% CI 1.01\u20131.62, P\u2009=\u20090.04), there was no difference in the number of women who gave birth to small for gestational age (SGA) infants (aOR 0.97, 95% CI 0.82\u20131.15, P\u2009=\u20090.72) between the women with PCOS and the reference group. Intrauterine foetal deaths (IUFDs) were also comparable between the two groups (aOR 1.03, 95% CI 0.68\u20131.59, P\u2009=\u20090.88). However, congenital anomalies were more likely to occur in the offspring of women with PCOS (aOR 1.89, 95% CI 1.51\u20132.38, P\u2009&lt;\u20090.001).<\/jats:p>\n <\/jats:sec>\n \n LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n This is a retrospective analysis utilising an administrative database which relies on the accuracy and consistency of the individuals coding the data. There are known limitations in how accurately hospital coding is able to capture perinatal conditions and complications, making it difficult to know with certainty that such events are accurate.<\/jats:p>\n <\/jats:sec>\n \n WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n Women with PCOS are more likely to experience adverse delivery and neonatal outcomes. It is important to additionally consider the risk of all other co-existing conditions frequently encountered in PCOS women, as these risks are additive and place women with PCOS at significantly increased risk of adverse pregnancy outcomes.<\/jats:p>\n <\/jats:sec>\n \n STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n No specific funding was obtained for this study. The authors have no conflicts of interest to disclose.<\/jats:p>\n <\/jats:sec>","DOI":"10.1093\/humrep\/deaa144","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T00:22:28Z","timestamp":1590193348000},"page":"1914-1921","source":"Crossref","is-referenced-by-count":65,"title":["Associations between polycystic ovary syndrome and adverse obstetric and neonatal outcomes: a population study of 9.1 million births"],"prefix":"10.1093","volume":"35","author":[{"given":"Ginevra","family":"Mills","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, McGill University Health Centre, McGill University, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Badeghiesh","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, McGill University Health Centre, McGill University, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Suarthana","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, McGill University Health Centre, McGill University, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitham","family":"Baghlaf","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, McGill University Health Centre, McGill University, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H","family":"Dahan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, McGill University Health Centre, McGill University, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"key":"2020080315203728500_deaa144-B1","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.fertnstert.2005.01.085","article-title":"Diagnostic criteria for polycystic ovary syndrome: a reappraisal","volume":"83","author":"Azziz","year":"2005","journal-title":"Fertil Steril"},{"key":"2020080315203728500_deaa144-B2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncpendmet0117","article-title":"How prevalent is metabolic syndrome in women with polycystic ovary syndrome?","volume":"2","author":"Azziz","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2020080315203728500_deaa144-B3","doi-asserted-by":"crossref","first-page":"247.e1","DOI":"10.1016\/j.ajog.2015.12.013","article-title":"Stein and leventhal: 80 years on","volume":"214","author":"Azziz","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"2020080315203728500_deaa144-B4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/MED.0000000000000079","article-title":"Changing perspectives in pre-existing diabetes and obesity in pregnancy: maternal and infant short- and long-term outcomes","volume":"21","author":"Barbour","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2020080315203728500_deaa144-B5","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","article-title":"A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"12","author":"Boomsma","year":"2006","journal-title":"Hum Reprod Update"},{"key":"2020080315203728500_deaa144-B6","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1210\/jc.2018-01787","article-title":"Pre-conception characteristics predict obstetrical and neonatal outcomes in women with polycystic ovary syndrome","volume":"104","author":"Christ","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2020080315203728500_deaa144-B7","doi-asserted-by":"crossref","first-page":"294","DOI":"10.23736\/S0391-1977.16.02482-2","article-title":"Cardiovascular disease in PCOS is related to severe insulin resistance, not mild","volume":"42","author":"Dahan","year":"2017","journal-title":"Minerva Endocrinol"},{"key":"2020080315203728500_deaa144-B8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s12020-019-01899-9","article-title":"Relationship among obesity, insulin resistance, and hyperinsulinemia in the polycystic ovary syndrome","volume":"64","author":"Dahan","year":"2019","journal-title":"Endocrine"},{"key":"2020080315203728500_deaa144-B9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.fertnstert.2017.06.015","article-title":"Increased rates of complications in singleton pregnancies of women previously diagnosed with polycystic ovary syndrome predominantly in the hyperandrogenic phenotype","volume":"108","author":"de Wilde","year":"2017","journal-title":"Fertil Steril"},{"key":"2020080315203728500_deaa144-B10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/09513590.2019.1631278","article-title":"Comparing pregnancy, childbirth, and neonatal outcomes in women with different phenotypes of polycystic ovary syndrome and healthy women: a prospective cohort study","volume":"36","author":"Foroozanfard","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"2020080315203728500_deaa144-B11","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/cen.13828","article-title":"Comorbidities and complications of polycystic ovary syndrome: an overview of systematic reviews","volume":"89","author":"Gilbert","year":"2018","journal-title":"Clin Endocrinol"},{"key":"2020080315203728500_deaa144-B12","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1093\/humrep\/15.9.1965","article-title":"Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist Ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation syndrome: preliminary report: short communication","volume":"15","author":"Itskovitz-Eldor","year":"2000","journal-title":"Hum Reprod"},{"key":"2020080315203728500_deaa144-B13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1055\/s-0035-1571195","article-title":"Polycystic ovary syndrome, obesity, and pregnancy","volume":"34","author":"Joham","year":"2016","journal-title":"Semin Reprod Med"},{"key":"2020080315203728500_deaa144-B14","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1210\/jc.2019-00383","article-title":"A narrative review of placental contribution to adverse pregnancy outcomes in women with polycystic ovary syndrome","volume":"104","author":"Kelley","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2020080315203728500_deaa144-B15","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/cen.13579","article-title":"Polycystic ovary syndrome and adverse pregnancy outcomes: current state of knowledge, challenges and potential implications for practice","volume":"88","author":"Khomami","year":"2018","journal-title":"Clin Endocrinol"},{"key":"2020080315203728500_deaa144-B16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/obr.12829","article-title":"Increased maternal pregnancy complications in polycystic ovary syndrome appear to be independent of obesity\u2014a systematic review, meta-analysis, and meta-regression","volume":"20","author":"Khomami","year":"2019","journal-title":"Obes Rev"},{"key":"2020080315203728500_deaa144-B17","doi-asserted-by":"crossref","first-page":"558.e1","DOI":"10.1016\/j.ajog.2011.03.021","article-title":"Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis","volume":"204","author":"Kjerulff","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"2020080315203728500_deaa144-B18","first-page":"2829","article-title":"Placental characteristics in women with polycystic ovary syndrome","volume":"30","author":"Koster","year":"2015","journal-title":"Hum Reprod"},{"key":"2020080315203728500_deaa144-B19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"key":"2020080315203728500_deaa144-B20","first-page":"32","article-title":"Polycystic ovary syndrome, body mass index and hypertensive disorders in pregnancy. Pregnancy Hypertens","author":"Lonnebotn","year":"2018"},{"key":"2020080315203728500_deaa144-B4655048","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deaa099","article-title":"Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies","author":"Mills","year":"2020","journal-title":"Hum Reprod"},{"key":"2020080315203728500_deaa144-B21","first-page":"1","article-title":"Complicating conditions associated with childbirth, by delivery method and payer, 2011: statistical brief #173","author":"Moore","year":"2006","journal-title":"Healthcare Cost and Utilization Project (HCUP) Statistical Briefs"},{"key":"2020080315203728500_deaa144-B22","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","article-title":"Polycystic ovary syndrome","volume":"370","author":"Norman","year":"2007","journal-title":"Lancet"},{"key":"2020080315203728500_deaa144-B23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.diabres.2018.04.030","article-title":"Polycystic ovary syndrome and hyperglycaemia in pregnancy. A narrative review and results from a prospective Danish Cohort Study","volume":"145","author":"Palm","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"2020080315203728500_deaa144-B24","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/humupd\/dmv029","article-title":"Pregnancy complications in women with polycystic ovary syndrome","volume":"21","author":"Palomba","year":"2015","journal-title":"Hum Reprod Update"},{"key":"2020080315203728500_deaa144-B25","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1210\/jc.2014-1214","article-title":"Low-grade chronic inflammation in pregnant women with polycystic ovary syndrome: a prospective controlled clinical study","volume":"99","author":"Palomba","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2020080315203728500_deaa144-B26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.rbmo.2014.04.010","article-title":"Early trophoblast invasion and placentation in women with different PCOS phenotypes","volume":"29","author":"Palomba","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"2020080315203728500_deaa144-B27","doi-asserted-by":"crossref","first-page":"754","DOI":"10.23736\/S0026-4784.18.04230-2","article-title":"Pregnancy complications in infertile patients with polycystic ovary syndrome: updated evidence","volume":"70","author":"Palomba","year":"2018","journal-title":"Minerva Ginecol"},{"key":"2020080315203728500_deaa144-B28","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.fertnstert.2009.10.043","article-title":"Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes","volume":"94","author":"Palomba","year":"2010","journal-title":"Fertil Steril"},{"key":"2020080315203728500_deaa144-B29","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1093\/humrep\/det250","article-title":"Macroscopic and microscopic findings of the placenta in women with polycystic ovary syndrome","volume":"28","author":"Palomba","year":"2013","journal-title":"Hum Reprod"},{"key":"2020080315203728500_deaa144-B30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1477-7827-11-56","article-title":"Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"11","author":"Qin","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"key":"2020080315203728500_deaa144-B31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"2020080315203728500_deaa144-B32","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.fertnstert.2015.11.019","article-title":"Pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization","volume":"105","author":"Sterling","year":"2016","journal-title":"Fertil Steril"},{"key":"2020080315203728500_deaa144-B33","doi-asserted-by":"crossref","first-page":"116940","DOI":"10.1016\/j.lfs.2019.116940","article-title":"Hyperandrogenemia and insulin resistance: the chief culprit of polycystic ovary syndrome","volume":"236","author":"Wang","year":"2019","journal-title":"Life Sci"},{"key":"2020080315203728500_deaa144-B34","doi-asserted-by":"crossref","first-page":"e4863","DOI":"10.1097\/MD.0000000000004863","article-title":"Association between polycystic ovary syndrome and the risk of pregnancy complications a PRISMA-compliant systematic review and meta-analysis","volume":"95","author":"Yu","year":"2016","journal-title":"Medicine"},{"key":"2020080315203728500_deaa144-B35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13098-019-0462-6","article-title":"Early pregnancy metabolic factors associated with gestational diabetes mellitus in normal-weight women with polycystic ovary syndrome: a two-phase cohort study","volume":"11","author":"Zheng","year":"2019","journal-title":"Diabetol Metab Syndr"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/35\/8\/1914\/33560392\/deaa144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/35\/8\/1914\/33560392\/deaa144.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T13:48:57Z","timestamp":1666619337000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/35\/8\/1914\/5869369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":36,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,7,9]]},"published-print":{"date-parts":[[2020,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deaa144","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,8]]},"published":{"date-parts":[[2020,7,9]]}}}